Far Infrared Radiation Treatment for Osteoarthritis
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by GAAD Medical Research Institute Inc..
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
GAAD Medical Research Institute Inc.
Information provided by:
GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier:
NCT00573352
First received: December 12, 2007
Last updated: January 2, 2009
Last verified: January 2009
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | December 12, 2007 | ||||||||
| Last Updated Date | January 2, 2009 | ||||||||
| Start Date ICMJE | September 2006 | ||||||||
| Primary Completion Date | February 2008 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE |
The primary end point is to determine the therapeutic effects of far infrared radiation on osteoarthritis [ Time Frame: 2 years and 9 months ] [ Designated as safety issue: No ] | ||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT00573352 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE |
The therapeutic effects of far infrared radiation on all forms of arthritis [ Time Frame: 2 years and 9 months ] [ Designated as safety issue: No ] | ||||||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Far Infrared Radiation Treatment for Osteoarthritis | ||||||||
| Official Title ICMJE | Phase 1 Study to Determine the Efficacy of Using Energy Specific Far Infrared (FIR) Radiation for the Treatment of Arthritis and Other Related Diseases | ||||||||
| Brief Summary | A study to evaluate the possibility of using far infrared radiation to manage pain due to osteoarthritis. |
||||||||
| Detailed Description | Arthritis consists of more than 100 different conditions. These conditions range from relatively mild forms such as tendonitis and bursitis to crippling forms as rheumatoid arthritis. Pain syndromes include fibromyalgia and arthritis-related disorders as lupus erythematosus that involve every part of the body. There are forms of the disease, such as gout that almost nobody connects with arthritis. Osteoarthritis is the most common form of arthritis. The objective for the study is to access the possibility of using far infrared radiation for pain management. |
||||||||
| Study Type ICMJE | Interventional | ||||||||
| Study Phase | Phase 1 | ||||||||
| Study Design ICMJE | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
||||||||
| Condition ICMJE | Osteoarthritis | ||||||||
| Intervention ICMJE | Radiation: Far Infrared
Far Infrared Radiation (5μm to 20μm wavelength). Duration is 30 to 40 minutes per session |
||||||||
| Study Arm (s) | 1
Far infrared radiation
Intervention: Radiation: Far Infrared |
||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Active, not recruiting | ||||||||
| Estimated Enrollment ICMJE | 2 | ||||||||
| Estimated Completion Date | December 2008 | ||||||||
| Primary Completion Date | February 2008 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | Not Provided | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||
| Location Countries ICMJE | Canada | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT00573352 | ||||||||
| Other Study ID Numbers ICMJE | GAAD-OA-CTP1 | ||||||||
| Has Data Monitoring Committee | Yes | ||||||||
| Responsible Party | Dr. Kwasi Donyina, GAAD Medical Research Institute Inc. | ||||||||
| Study Sponsor ICMJE | GAAD Medical Research Institute Inc. | ||||||||
| Collaborators ICMJE | Not Provided | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | GAAD Medical Research Institute Inc. | ||||||||
| Verification Date | January 2009 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||